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Simple Summary: Pigs with porcine endogenous retrovirus (PERV) inactivation are preferable donor
sources for xenotransplantation because the PERV may act as an infectious pathogen for humans who
receive pig organ xenotransplantation. However, inactivation of the PERV pol gene in porcine cells
reportedly affects cell growth. The present study clarified the relationship between the mutation of the
PERV pol gene in porcine embryos and their development. Three different gRNAs targeting the PERV
pol gene were introduced into porcine zygotes by genome editing using electroporation of the Cas9
protein (GEEP) system. The results demonstrated a negative relationship between the embryonic
development and the efficiency of target mutations in the PERV pol gene of the porcine embryos.
Abstract: Porcine endogenous retrovirus (PERV) is a provirus found in the pig genome that may act
as an infectious pathogen in humans who receive pig organ xenotransplantation. Inactivation of the
PERV pol gene in porcine cells reportedly affects cell growth. Therefore, the mutation of PERV pol
gene in porcine embryos using genome editing may affect the embryonic development. The present
study was carried out to investigate the relationship between the mutation of the PERV pol gene
in porcine embryos and their development. We introduced, either alone or in combination, three
different gRNAs (gRNA1, 2, and 3) into porcine zygotes by genome editing using electroporation of
the Cas9 protein (GEEP) system. All three gRNAs targeted the PERV pol gene, and we assessed their
effects on porcine embryonic development. Our results showed that the blastocyst formation rates of
zygotes electroporated with gRNA3—alone and in combination—were significantly lower (p < 0.05)
than those of zygotes electroporated with gRNA1. The mutation rates assessed by the PERV pol gene
target site sequencing in individual blastocysts and pooled embryos at the 2-to-8-cell stage did not
differ among the three gRNAs. However, the frequency of indel mutations in mutant embryos at the
2-to-8-cell stage trended higher in the embryos electroporated with gRNA3 alone and in combination.
Embryonic development may be affected by gRNAs that induce high-frequency indel mutations.
Keywords: electroporation; GEEP; genome editing; PERV; pol gene
1. Introduction
Organ transplantation is an established, effective, and safe tool for treating patients with end-stage
organ failure. Xenotransplantation (cross-species transplantation) has evolved as an attempt to resolve
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critical shortages of human organs [1]. Genetic engineering and cloning technologies allow porcine
tissues that are used for xenotransplantation to be protected from human immune responses [1].
However, the health and safety of xenotransplantation is an area of ongoing concern. In particular,
porcine tissues may cause zoonosis in the recipient following xenotransplantation [2,3].
Endogenous retroviruses are viral elements integrated and transmitted vertically through the
germline, and are then transmitted to subsequent generations [4,5]. Porcine endogenous retrovirus
(PERV) may act as an infectious disease in humans that should be closely monitored during and after
xenotransplantation. PERVs have single-stranded RNA (ssRNA) genomes, which contain gag, pol,
and env genes [6]. The gag gene encodes a structural protein, and the env gene encodes an envelope
protein that plays an important role in the infection of host cells [7–9]. The pol gene encodes protease,
reverse transcriptase, and integrase, and plays a crucial role in the replication cycle of retroviruses
because it transcribes genomic RNA into double-stranded DNA (dsDNA), called the provirus, which
is subsequently integrated into the genome of the host cell [2–4,6,10]. The PERV copy numbers vary
among different breeds of pig, and among multiple organs within each animal [3]. European wild boar
and Chinese miniature pigs contain fewer PERV copies than Western breeds [11,12]. Pigs with low
PERV copy number or PERV inactivation are preferable donor sources for xenotransplantation.
Clustered regularly interspaced short palindromic repeats-associated protein 9 nuclease
(CRISPR/Cas9) is a powerful genome-editing tool used with animals and plants [13,14]. Recently, Yang
et al. [15] reported that all PERVs in a porcine kidney epithelial cell line could be inactivated using the
CRISPR/Cas9 system. However, DNA cleavage via the CRISPR/Cas9 system at multiple PERV sites in
the genome of porcine cells may trigger DNA-damage-induced senescence or apoptosis, resulting in
poor growth of the modified cells [16]. In a previous study, we demonstrated that the type of gRNA
affected the development of porcine embryos edited by the CRISPR/Cas9 system. This indicated that
the targeting of the genomic region by gRNA caused embryonic lethality [17]. However, there is no
information on the development and target mutations in the PERV pol gene of porcine embryos after
the introduction of the CRISPR/Cas9 system by electroporation.
To clarify the effects of PERV pol gene mutation on the development of porcine embryos, we
investigated the relationship between the embryonic development and the efficiency of target mutations
in the PERV pol gene on porcine zygotes edited by three different gRNAs, either alone or in combination,
using the genome editing by electroporation of the Cas9 protein (GEEP) system.
2. Materials and Methods
2.1. General
All procedures were approved by the Animal Research Committee of Tokushima University
(ethical code: T28-21).
2.2. Oocyte Collection, in Vitro Maturation, Fertilization, and Embryo Culture
Oocyte collection, in vitro maturation, fertilization, and embryo culture were carried out as
described previously [13]. We obtained about 200 ovaries from prepubertal crossbred gilts (Landrace
× Large White × Duroc breeds) at a local slaughterhouse. Ovaries were washed three times with
modified phosphate-buffered saline (m-PBS; Nihonzenyaku, Fukushima, Japan) supplemented with
100 IU/mL penicillin G potassium (Meiji, Tokyo, Japan) and 0.1 mg/mL streptomycin sulfate (Meiji). The
cumulus-oocyte complexes (COCs) were collected from 3–6-mm follicles using a surgical blade. The
COCs with a uniform ooplasm and compact cumulus cell mass were cultured in maturation medium
at 39 ◦C in a humidified incubator containing 5% CO2. The maturation medium consisted of 25 mM
HEPES tissue culture medium 199 with Earle’s salts (TCM 199; Invitrogen Co., Carlsbad, CA, USA),
supplemented with 10% (v/v) porcine follicular fluid, 0.6 mM cysteine (Sigma-Aldrich, St. Louis, MO,
USA), 50 µM sodium pyruvate (Sigma-Aldrich), 2 mg/mL d-sorbitol (Wako Pure Chemical Industries
Ltd., Osaka, Japan), 50 µM β-mercaptoethanol (Wako Pure Chemical Industries Ltd.), 10 IU/mL equine
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chorionic gonadotropin (Kyoritu Seiyaku, Tokyo, Japan), 10 IU/mL human chorionic gonadotropin
(Kyoritu Seiyaku, Tokyo, Japan), and 50 µg/mL gentamicin (Sigma-Aldrich, St. Louis, MO, USA).
After maturation for 20 to 22 h, the COCs were cultured for an additional 24 h in maturation medium
without hormones under the same conditions.
For in vitro fertilization (IVF), frozen–thawed boar spermatozoa (Landrace breed) were transferred
into 6 mL of porcine fertilization medium (PFM; Research Institute for the Functional Peptides Co.,
Yamagata, Japan) and washed by centrifuging at 500× g for 5 min. The pelleted spermatozoa were
resuspended in PFM and adjusted to 5 × 106 cells/mL. Then, the matured oocytes were transferred to
the sperm-containing PFM and co-incubated in a humidified incubator containing 5% CO2, 5% O2,
and 90% N2 for 5 h at 39 ◦C.
After IVF, the zygotes were washed with pig zygote medium (PZM-5; Research Institute for the
Functional Peptides Co.) and were cultured continuously in vitro at 39 ◦C in a humidified incubator
containing 5% CO2, 5% O2, and 90% N2. All of the cleaved embryos were transferred into 100-µL
droplets of porcine blastocyst medium (PBM, Research Institute for the Functional Peptides Co.) 72 h
after insemination. The embryos were subsequently cultured for an additional 4 days to evaluate their
ability to develop to the blastocyst stage.
2.3. Electroporation
Three different gRNAs targeting the PERV pol gene were designed; the target sequences were as
follows: (1) sgRNA1: 5′- GGTGACCCTCCTCCAGTACG-3′, (2) sgRNA2: 5′- GTCATCCACGTACT
GGAGGA-3′, and (3) sgRNA3: 5′- GGTAGCAGGGGAGTATTCCA-3′. gRNAs were designed using
the CRISPR direct webtool (https://crispr.dbcls.jp/) [18]. The PAM sequence was set as NGG. We selected
the gRNAs which targeted the sequence conserved in PERV-A, PERV-B, and PERV-C (Figure 1), because
PERV-A and PERV-B have been reported to infect several mammalian species, including human [10,19].
Moreover, PERV-A/C resulting from the recombination of subtypes A and C has been demonstrated
to be infectious to human cells and to show higher replication titers than PERV-A [20]. Since the
Cas9 protein has been reported as intolerable for mismatches at the 3’ end of the gRNAs [21,22],
we confirmed that 12 bases at the 3’ end of gRNA had no identical sequence in the pig genome other
than the region expected for the PERV pol gene to minimize the possibility of the off-target effect using
the COSMID webtool (https://crispr.bme.gatech.edu/) [23]. Electroporation was performed 13 h after
the initiation of IVF as described previously [24]. Briefly, an electrode (LF501PT1-20; BEX, Tokyo, Japan)
was connected to a CUY21EDIT II electroporator (BEX, Tokyo, Japan) and placed under a stereoscopic
microscope. The putative zygotes (approximately 30–40 zygotes) were washed with Opti-MEM I
solution (Thermo Fisher Scientific K.K., Tokyo, Japan) and placed in a line in the electrode gap, in a
chamber slide filled with 10 µL of Opti-MEM I solution with 100 ng/µL of Cas9 protein and 10 ng/µL
of gRNA targeting the PERV pol gene. They were then electroporated by 25 V/mm, 1 ms, and five
repeats (Figure 2). After electroporation, the zygotes were cultured to examine the effect of different
gRNAs targeting the PERV pol gene on the development of electroporated zygotes. We demonstrated
that there was no difference in the embryonic survival after in vitro culture between electroporation
procedures with and without gRNA and Cas9 protein [25]. Thus, as a control, some zygotes were
cultured with PZM-5 and PBM for 7 days without performing electroporation.
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Figure 1. Genomic structure of porcine endogenous retrovirus (PERV) and gRNA locations targeting the
pol gene. Three types of gRNAs (arrows) are shown in the alignments of PERV-A, PERV-B, and PERV-C
pol genes.
Figure 2. Schemes of genome editing using the electroporation method. Approximately 30–40 putative
zygotes were placed in a line in the electrode gap, in a chamber slide filled with 10 µL of Opti-MEM
I solution with Cas9 protein and gRNA, and were then electroporated by 25 V/mm, 1 ms, and five
repeats. IVF: in vitro fertilization.
2.4. Analysis of Targeted Gene Sequence
We analyzed the frequencies of base insertions or deletions (indels) in the PERV pol gene of
individual blastocysts and pooled embryos at the 2-to-8-cell stage in order to compare the efficiency of
target mutations in the embryos among the three gRNAs groups. The embryos at the 2-to-8-cell stage in
each gRNA group were randomly collected 3 days after the electroporation treatment. The total number
of blastomeres in the collected embryos per sample was adjusted to 16 in order to avoid cleavage
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stage bias. The genomic DNA of embryos was extracted using a heat treatment in 50 mM NaOH after
neutralization. The DNA samples were subjected to PCR using Quick Taq HS DyeMix (Toyobo, Osaka,
Japan) according to the manufacturer’s instructions. Primers used for amplification were: sgRNA1, 2:
5′- GATGCCTTCTTCTGCCTGAG -3′ (forward) and 5′ TTGGTTAGCGGGTAGAGTGG -3′ (reverse);
sgRNA3: 5′- TTGAATAACCTGTGGGGGAA -3′ (forward) and 5′- TACTGGAGGAGGGTCACCTG
-3′ (reverse). After purification of PCR products with a Fast Gene Gel/PCR Extraction Kit (Nippon
Genetics, Tokyo, Japan), we analyzed the target region sequences using Sanger sequencing with a
BigDye Terminator Cycle Sequencing Kit version 3.1 (Thermo Fisher Scientific K.K., Tokyo, Japan) in
an ABI 3500 genetic analyzer (Thermo Fisher Scientific K.K., Tokyo, Japan). We used a Tracking of
Indels by Decomposition (TIDE; https://tide.deskgen.com/) bioinformatics package to quantify the
frequency of indel mutation events in embryos electroporated with PERV pol gRNA [26]. According
to the target region sequences, they were classified as “wild-type” or “mosaic mutant,” in which the
presence of different alleles with wild-type alleles was considered mosaic.
2.5. Statistical Analysis
Data pertaining to embryonic development and mutation efficiency were evaluated using the
analysis of variance (ANOVA) test followed by Fisher’s protected least significant difference (PLSD)
test using STATVIEW (Abacus Concepts, Inc., Berkeley, CA, USA) [27]. All percentage data were
subjected to arcsin transformation before ANOVA tests. The percentages of mutations within all
blastocysts and samples of pooled embryos were analyzed using a chi-squared analysis with Yates’
correction. Differences with a probability value (p) of 0.05 or less were regarded as significant.
3. Results
We examined the effects of gRNA alone (Table 1) and in combination (Table 2) targeting the PERV
pol gene on the development of embryos and their mutation. The electroporation treatment with
gRNAs targeting the PERV pol gene decreased the rate of blastocyst formation in zygotes compared to
untreated zygotes, irrespective of the type and combination of gRNA. In the embryos electroporated
with each gRNA, the blastocyst formation rate in zygotes electroporated with gRNA3 was significantly
lower (p < 0.05) than that in zygotes electroporated with gRNA1 (Table 1). Similarly, combining
gRNA3 with the other gRNA significantly decreased the blastocyst formation rate as compared with
the combination of gRNA1 and gRNA 2 (p < 0.05) (Table 2). When the mutation rates were assessed by
sequencing the target sites of the PERV pol gene in individual blastocysts, the rates did not differ among
the three groups, irrespective of the types or combinations of gRNA. Similarly, when the frequency of
indel mutations (mutation efficiency) in mutant blastocysts was examined by TIDE (Figure 3), there
were no significant between-group differences.
Since we were unable to obtain a sufficient number of blastocysts from zygotes electroporated
with gRNA3 (either alone or in combination), we examined the mutation rates and mutation efficiency
of pooled embryos at the 2-to-8-cell stage (Table 3). The mutation rates in the samples of pooled
embryos ranged from 80.0%–100% and were similar across all groups, irrespective of the types and
combinations of gRNA. The mutation efficiency of mutant embryos in the single gRNA3 group was
significantly higher (p < 0.05) than in the single gRNA2 group, but similar to that in the single gRNA1
group. However, the combination of gRNA3 with the other gRNA significantly increased the mutation
efficiency as compared with the combination of gRNA1 and gRNA 2 (p < 0.05).
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Figure 3. Representative result of Sanger sequencing analysis after the introduction of gRNA targeting
the PERV pol gene and Cas9 protein, and the frequencies of indel mutation quantified by a Tracking of
Indels by Decomposition (TIDE) analysis. Sanger sequencing results obtained from the blastocysts
developed after the introduction of gRNA# 1 are shown. (a) Analysis of wild-type blastocyst.
(b,c) Analysis of the genome-edited blastocyst. Example of the result showing relatively low (b; 9.4%
of 1 bp insertion) or high (c; 21.0% of 1 bp insertion) indel frequency. Arrowhead indicates the Cas9
cleavage site. Nucleotides in blue color indicate target sequence of PERV#1 gRNA, and nucleotides in
red color indicate protospacer adjacent motif (PAM) sequences.
Table 1. Effects of gRNA targeting the PERV pol gene on the development of electroporated zygotes
and the mutation in the blastocysts †.
gRNA †† No. of Oocytes
Examined








(Mean ± SEM) ††††Cleaved
Developed to
Blastocysts
Control 184 159 (86.1± 1.5) 41 (21.5 ± 3.9) a - - -
gRNA1 267 227 (85.1 ± 2.6) 22 (9.2 ± 3.4) b 18 13 (72.2) 12.4 ± 2.2
gRNA2 263 220 (83.9 ± 2.4) 11 (4.3 ± 1.6) b,c 10 5 (50.0) 11.8 ± 2.1
gRNA3 263 224 (85.5 ± 3.1) 1 (0.4 ± 0.4) c 1 1 (100) 18.1
† Five replicate trials were completed. †† Electroporation was performed by 1 ms and five pulses at 25 V/mm. As a
control, the zygotes were cultured without performing electroporation. ††† The proportions were calculated by
dividing the number of mosaic mutant blastocysts by the total number of sequenced blastocysts. †††† The mean
proportions represent the proportion of indel mutation events in mosaic mutant blastocysts determined by the TIDE
bioinformatics package. a–c Values with different superscripts in the same column are significantly different (p < 0.05).
Table 2. Effects of gRNAs in combination targeting the PERV pol gene on the development of
electroporated zygotes and mutations in the blastocysts †.
gRNA †† No. of Oocytes
Examined







SEM) ††††Cleaved Developed toBlastocysts
Control 157 124 (79.4 ± 3.2) a 28 (14.4 ± 1.5) a - - -
gRNA1 &
gRNA2 230
204 (88.9 ± 2.1)
b 11 (4.7 ± 1.0) b 10 8 (80.0) 11.0 ± 3.1
gRNA1 &
gRNA3 197 146 (74.0 ± 3.2)
a 2 (1.1 ± 0.6) c 2 1 (50.0) 15.9
gRNA2 &
gRNA3 222 174 (78.8 ± 4.6)
a 0 (0) c - - -
† Four replicate trials were carried out. †† Electroporation was performed by 1 ms and five pulses at 25 V/mm. As a
control, the zygotes were cultured without performing electroporation. ††† The proportions were calculated by
dividing the number of mosaic mutant blastocysts by the total number of sequenced blastocysts. †††† The mean
proportions represent the proportion of indel mutation events in mosaic mutant blastocysts determined by the TIDE
bioinformatics package. a–c Values with different superscripts in the same column are significantly different (p < 0.05).
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Table 3. Mutation rate and efficiency in pooled embryos at the 2-to-8-cell stage derived from zygotes









(Mean ± SEM) ††
gRNA1 10 10 (100) 32.9 ± 3.1 a,b
gRNA2 9 8 (88.9) 17.1 ± 2.9 a
gRNA3 8 8 (100) 44.0 ± 5.1 b
gRNA1 & gRNA2 15 12 (80.0) 21.1 ± 4.1 a
gRNA1 & gRNA3 16 14 (87.5) 59.9 ± 6.2 c
gRNA2 & gRNA3 10 10 (100) 42.2 ± 5.8 b
† The proportions were calculated by dividing the number of mutated embryo sample by the total number of
sequenced embryo sample. †† The mean proportions represent the proportion of indel mutation events in the
mutated embryo sample determined by the TIDE bioinformatics package. a–c Values with different superscripts in
the same column are significantly different (p < 0.05).
4. Discussion
The three major proteins encoded within the PERV genome are gag, pol, and env. The pol
gene produces a reverse transcriptase that assists viral replication and infection [15]. Disruption
of the PERV pol genes, which are necessary for viral replication in porcine kidney cells, using
CRISPR/Cas9 could reduce the transmission of PERV to human cells by more than 1000-fold [15].
Targeting the pol gene did not interfere with normal placental function in pigs [28], suggesting
that pol genes are ideal sites for gene editing. If the pol gene could be interrupted at a particular
site, the virus would not be able to multiply inside the body of the pigs, improving the safety of
xenotransplantation. We designed and tested three different constructs of gRNA that targeted the
PERV pol gene to determine if these gRNAs could increase the mutation efficiency with suitable
embryonic developmental competence.
We determined the relationship between embryonic development and the efficiency of target
mutations in the PERV pol gene. The embryonic cleavage rate is a biological indicator of developmental
potential, and the blastocyst formation rate of slow-cleaving embryos is low in mice [29]. Timing
of first embryonic cleavage is also a positive indicator of the developmental potential of porcine
in vitro fertilized zygotes [30]. In the present study, several cleaved embryos were monitored after
electroporation with three gRNAs, either alone or in combination. Our results showed that the type
of gRNA had no apparent effect on the embryonic cleavage rates, but affected the rate of blastocyst
formation in zygotes. The blastocyst formation rate of zygotes electroporated with gRNA3 alone
decreased compared to zygotes electroporated with gRNA1 alone. Moreover, the combination of
gRNA3 with the other gRNA decreased the blastocyst formation rate of zygotes. These results
are consistent with our previous report, which demonstrated that the type of gRNA affected the
development of porcine embryos edited by the CRISPR/Cas9 system [17].
On the other hand, sequence features or type of gRNA could affect the success of the CRISPR/Cas9
targeting system [31]. Moreover, DNA cleavages by the CRISPR/Cas9 system at multiple PERV sites
triggered DNA damage-induced senescence or apoptosis, affecting the growth of the mutated cells [16].
Previous studies reported that the number of copies of PERV genes differed relative to the breed,
with commercial Western pigs containing more PERV copies than wild and native pigs [11,12,32,33].
The PCR titration analysis detected 32–64 pol copies in Landrace×Duroc crossbred pigs [34]. Therefore,
when the CRISPR/Cas9 system edited porcine embryos from Western commercial breeds with gRNAs
targeting the PERV pol gene, more DNA cleavages at multiple PERV sites seemed to occur. We used
porcine zygotes derived from ovaries and semen in Western breeds, and subjected the zygotes to
electroporation treatment with gRNAs targeting the PERV pol gene. The mutation efficiency in the
mutant embryos at the 2-to-8-cell stage trended to be higher in the embryos electroporated with
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gRNA3 alone and in combination, which decreased the blastocyst formation rate of the zygotes. Since
PERV exists in multiple copies in the pig genome, the high editing efficiency observed in the embryos
electroporated with gRNA3 alone and in combination might induce the simultaneous cleavage of
DNA, resulting in low embryonic development. Therefore, in Western breeds with more PERV copies,
embryonic development may relate to the efficiency of target mutations in the PERV pol genes of the
modified embryos.
In conclusion, we found a negative relationship between embryonic development and the
efficiency of target mutations in the PERV pol gene of porcine embryos. Further studies should attempt
to elucidate additional technical points, including the type and combination of gRNAs targeting
the pol gene. This information will enhance favorable outcomes related to PERV pol gene-edited
pig production.
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